{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:59:37Z","timestamp":1791644377531,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ajog.2025.04.020","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T18:57:52Z","timestamp":1744743472000},"page":"263.e1-263.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The association between serum soluble fms-like tyrosine kinase-1, placental growth factor, and soluble fms-like tyrosine kinase-1\/placental growth factor ratio in singleton pregnancy and placental abruption: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"233","author":[{"given":"Katarzyna","family":"Kosi\u0144ska-Kaczy\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-5428","authenticated-orcid":false,"given":"Iwona","family":"Szymusik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brawura Biskupski Samaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Sys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.04.020_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semperi.2014.03.002","article-title":"Prediction and prevention of ischemic placental disease","volume":"38","author":"Friedman","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2025.04.020_bib2","doi-asserted-by":"crossref","first-page":"19009","DOI":"10.3390\/ijms160819009","article-title":"Angiogenesis-related biomarkers (sFlt-1\/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration","volume":"16","author":"Herraiz","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2025.04.020_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/aogs.12030","article-title":"Decreasing perinatal mortality in placental abruption","volume":"92","author":"Tikkanen","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2025.04.020_bib4","doi-asserted-by":"crossref","first-page":"S1313","DOI":"10.1016\/j.ajog.2022.06.059","article-title":"Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management","volume":"228","author":"Brandt","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.04.020_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125246","article-title":"An international contrast of rates of placental abruption: an age-period-cohort analysis","volume":"10","author":"Ananth","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.04.020_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.semperi.2009.02.005","article-title":"Abruptio placentae and disseminated intravascular coagulopathy","volume":"33","author":"Hall","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2025.04.020_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.AOG.0000216014.72503.09","article-title":"Circulating angiogenic factors and placental abruption","volume":"108","author":"Signore","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.04.020_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134-135","author":"Staff","year":"2019","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2025.04.020_bib9","doi-asserted-by":"crossref","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.04.020_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.04.020_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.04.020_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/pd.1869","article-title":"Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption","volume":"27","author":"Tikkanen","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2025.04.020_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2025.04.020_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265080","article-title":"The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia","volume":"17","author":"Aminuddin","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.04.020_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.04.020_bib16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"PARROT trial group. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.04.020_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/uog.23645","article-title":"Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China","volume":"58","author":"Hu","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.04.020_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006005","article-title":"Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes","volume":"96","author":"Lea\u00f1os-Miranda","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajog.2025.04.020_bib19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/HYPERTENSIONAHA.111.00754","article-title":"Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia","volume":"61","author":"Lea\u00f1os-Miranda","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.04.020_bib20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (soluble fms-like tyrosine kinase-1\/placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia","volume":"76","author":"Lea\u00f1os-Miranda","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.04.020_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126815","article-title":"Circulating angiogenic factors and the risk of adverse outcomes among Haitian women with preeclampsia","volume":"10","author":"March","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.04.020_bib22","article-title":"Adverse pregnancy outcomes and imbalance in angiogenic growth mediators and oxidative stress biomarkers is associated with advanced maternal age births: a prospective cohort study in Ghana","volume":"13","author":"Odame","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.04.020_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2025.04.020_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/uog.24851","article-title":"Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia","volume":"59","author":"Reddy","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.04.020_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/10641955.2016.1148162","article-title":"KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes","volume":"35","author":"Salahuddin","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2025.04.020_bib26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.117.09913","article-title":"Angiogenic markers predict pregnancy complications and prolongation in preeclampsia: continuous versus cutoff values","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.04.020_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10641955.2017.1334800","article-title":"Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction","volume":"36","author":"Shinohara","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2025.04.020_bib28","first-page":"1788","article-title":"Correlation analysis of serum placental growth factor, pregnancy-related plasma protein-A and disease severity in patients with hypertensive disorder in pregnancy","volume":"25","author":"Sun","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ajog.2025.04.020_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12884-015-0624-y","article-title":"Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia","volume":"15","author":"Turpin","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2025.04.020_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.ajog.2025.04.020_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejogrb.2022.01.017","article-title":"Serum biomarkers of maternal morbidity and adverse outcome in severe pre-eclampsia","volume":"270","author":"Keepanasseril","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2025.04.020_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/uog.13224","article-title":"Uterine artery Doppler and sFlt-1\/PlGF ratio: prognostic value in early-onset pre-eclampsia","volume":"43","author":"G\u00f3mez-Arriaga","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.04.020_bib33","article-title":"Correlation of sFlt\/PlGF ratio with severity of preeclampsia in an Indian population","volume":"3","author":"Kumar","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.ajog.2025.04.020_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mefs.2013.01.012","article-title":"Maternal serum concentrations of angiogenic and antiangiogenic factors in threatened miscarriage at 7-12 weeks' gestation and the risk of adverse pregnancy outcomes","volume":"18","author":"Elkholi","year":"2013","journal-title":"Middle East Fertility Society Journal"},{"key":"10.1016\/j.ajog.2025.04.020_bib35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/AOG.0000000000003694","article-title":"Placental growth factor and the risk of adverse neonatal and maternal outcomes","volume":"135","author":"Parchem","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.04.020_bib36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0412.2010.01030.x","article-title":"Placental abruption: epidemiology, risk factors and consequences","volume":"90","author":"Tikkanen","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2025.04.020_bib37","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.04.020_bib38","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/HYPERTENSIONAHA.113.02664","article-title":"Strategy for standardization of preeclampsia research study design","volume":"63","author":"Myatt","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.04.020_bib39","article-title":"First-trimester PlGF and PAPP-A and the risk of placenta-mediated complications: PREDICTION prospective study","volume":"47","author":"C\u00f4t\u00e9","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2025.04.020_bib40","doi-asserted-by":"crossref","first-page":"363.e1","DOI":"10.1016\/j.ajog.2024.05.050","article-title":"Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing","volume":"231","author":"Espinoza","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.04.020_bib41","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s43032-024-01540-9","article-title":"The sFLT-1\/PlGF ratio for the prediction of preeclampsia-related adverse fetal and maternal outcomes in women with preexisting diabetes","volume":"31","author":"Provendier","year":"2024","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2025.04.020_bib42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.preghy.2022.03.009","article-title":"Longitudinal changes in angiogenesis biomarkers within 72 h of diagnosis and time-to-delivery in early-onset preeclampsia","volume":"28","author":"Villalain","year":"2022","journal-title":"Pregnancy Hypertens"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825002273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825002273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:32:20Z","timestamp":1761431540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825002273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0002937825002273"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.04.020","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between serum soluble fms-like tyrosine kinase-1, placental growth factor, and soluble fms-like tyrosine kinase-1\/placental growth factor ratio in singleton pregnancy and placental abruption: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}